Citigroup
NAUT icon

Citigroup’s Nautilus Biotechnolgy NAUT Stock Holding History

Citigroup’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1K Buy
23,072
+1,930
+9% +$5.1K ﹤0.01% 5011
2026
Q1 		$82K Sell
21,142
-40,570
-66% -$99.7K ﹤0.01% 4350
2025
Q4 		$120K Buy
61,712
+60,828
+6,881% +$99.7K ﹤0.01% 4247
2025
Q3 		$747 Sell
884
-3,729
-81% -$2.74K ﹤0.01% 5666
2025
Q2 		$3.34K Sell
4,613
-29,140
-86% -$21.9K ﹤0.01% 5323
2025
Q1 		$29.1K Sell
33,753
-6,819
-17% -$10.1K ﹤0.01% 5012
2024
Q4 		$68.2K Buy
40,572
+1,590
+4% +$3.8K ﹤0.01% 4994
2024
Q3 		$111K Buy
38,982
+24,524
+170% +$63.5K ﹤0.01% 4720
2024
Q2 		$33.8K Buy
14,458
+3,663
+34% +$9.56K ﹤0.01% 4795
2024
Q1 		$31.7K Buy
10,795
+382
+4% +$1.08K ﹤0.01% 4870
2023
Q4 		$31.1K Buy
10,413
+7,787
+297% +$22.3K ﹤0.01% 4782
2023
Q3 		$8.3K Sell
2,626
-15,334
-85% -$49.9K ﹤0.01% 4584
2023
Q2 		$69.5K Buy
17,960
+15,731
+706% +$45.3K ﹤0.01% 4441
2023
Q1 		$6.17K Sell
2,229
-458
-17% -$961 ﹤0.01% 4888
2022
Q4 		$4.84K Sell
2,687
-295
-10% -$569 ﹤0.01% 5036
2022
Q3 		$6K Sell
2,982
-2,299
-44% -$5.78K ﹤0.01% 5176
2022
Q2 		$14K Sell
5,281
-5,106
-49% -$19K ﹤0.01% 5194
2022
Q1 		$45K Buy
10,387
+5,877
+130% +$24.1K ﹤0.01% 4768
2021
Q4 		$23K Buy
4,510
+3,325
+281% +$17.8K ﹤0.01% 5348
2021
Q3 		$7K Hold
1,185
– – ﹤0.01% 5546
2021
Q2 		$12K Hold
1,185
– – ﹤0.01% 5575
2021
Q1 		$16K Buy
+1,185
New +$16.4K ﹤0.01% 5372

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Citigroup's NAUT Position: Q2 2026 in Review

Citigroup increased its Nautilus Biotechnolgy (NAUT) stake by 9.1% in Q2 2026, buying an estimated $5.1K and bringing the position to 23,072 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5011.

Citigroup first reported a position in NAUT in Q1 2021 and has held it in 22 quarters since. The position peaked at $120K in Q4 2025. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Citigroup held 23,072 shares of Nautilus Biotechnolgy worth $43.1K as of Q2 2026.
  • Citigroup bought 1,930 Nautilus Biotechnolgy shares in Q2 2026, an estimated $5.1K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5011 holding.
  • Citigroup first reported a position in Nautilus Biotechnolgy in Q1 2021 and has held it in 22 quarters since.
  • Citigroup's Nautilus Biotechnolgy position peaked at $120K in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.